Cefuroxime
0,75 g, 1,5 g № 1, № 5, № 50
Group of action
Active ingredient
Dosage form
Powder for solution for injections
ATC code
J01DС02
RX/OTC
RX
Marketing authorisation no.
UA/15365/01/01
General properties
Pharmacotherapeutic group
Antibacterial agents for systemic use. Second generation cephalosporins.
Indications
- Treatment of infections caused by microorganisms susceptible to cefuroxime, or treatment of infections before determining the causative agent of an infectious disease.
- Infectious diseases of the respiratory tract: acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infections of the chest organs;
- infectious diseases of the throat, nose: sinusitis, tonsillitis, pharyngitis;
- infectious diseases of the urinary tract: acute and chronic pyelonephritis, cystitis, asymptomatic bacteriuria;
- soft tissue infections: cellulitis, erysipeloid, wound infections;
- infectious diseases of bones and joints: osteomyelitis, septic arthritis;
- infections in obstetrics and gynecology: infectious and inflammatory diseases of the pelvic organs;
- gonorrhea, especially in cases when penicillin is contraindicated;
- other infectious diseases, including septicemia and meningitis.
- Prevention of the occurrence of infectious complications after operations on the chest and abdominal cavity, on the pelvic organs, in vascular, cardiovascular and orthopedic operations.
- In most cases, cefuroxime monotherapy is effective, but if necessary, the drug can be used in combination with aminoglycoside antibiotics or with metronidazole (orally, in suppositories or by injection).
- In the case of existing or anticipated mixed aerobic and anaerobic infections (for example, peritonitis, aspiration pneumonia, lung abscess, pelvic and brain organs) and the likelihood of such an infection (for example, in operations on the large intestine and in gynecological surgery), it is acceptable to use cefuroxime in combination with metronidazole.
- When treating pneumonia and exacerbation of chronic bronchitis, cefuroxime can be prescribed before oral administration of cefuroxime axetil, when necessary.
Pharmaceutical characteristics
Basic physical and chemical properties
White or almost white powder.
Shelf life
2 years.
Storage conditions
Keep out of the reach of children in the original packaging at a temperature not exceeding 25 °C.
After dilution, the drug can be stored up to 48 hours in the refrigerator (from 2 °C to 8 °C) or up to 5 hours at a temperature not higher than 25 °C.
Manufacturer
PJSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.
